Department of Analytical Chemistry, Kyoto Pharmaceutical University, Misasagi, Yamashina-ku, Kyoto, Japan.
J Microencapsul. 2010;27(5):453-9. doi: 10.3109/02652040903515482.
Lipid nano-emulsions (LNEs) having a mean droplet size of approximately 50 nm were investigated as drug carriers for paclitaxel (TXL) to achieve its satisfactory loadings and to develop a pharmaceutically acceptable alternative to the current formulation, Taxol. TXL was incorporated into the LNEs at 2.0 mg/ml without changes in particle size or drug precipitation. In the cytotoxicity study, TXL-loaded LNEs had cytotoxicity to HeLa cells equivalent to that of TXL alone; the 50% growth inhibitory concentrations (IC(50)) of TXL-loaded LNEs and TXL alone were 1.53 +/- 0.23 nM and 1.76 +/- 0.08 nM, respectively. However, a cellular accumulation study using 1,6-diphenyl-1,3,5-hexatriene (DPH) as a fluorescent probe showed that the accumulation of DPH-loaded LNEs in HeLa cells was remarkably lower than that of DPH alone. These results indicated that LNEs were a useful vehicle for TXL, even though LNEs themselves could not be efficiently accumulated in HeLa cells.
将平均粒径约为 50nm 的脂质纳米乳液(LNEs)作为紫杉醇(TXL)的药物载体进行研究,以实现其满意的载药量,并开发出一种可接受的替代当前制剂Taxol 的方法。TXL 以 2.0mg/ml 的浓度被包载到 LNEs 中,而粒径或药物沉淀没有发生变化。在细胞毒性研究中,载有 TXL 的 LNEs 对 HeLa 细胞的细胞毒性与单独的 TXL 相当;载有 TXL 的 LNEs 和 TXL 单独的 50%生长抑制浓度(IC50)分别为 1.53 +/- 0.23 nM 和 1.76 +/- 0.08 nM。然而,使用 1,6-二苯基-1,3,5-己三烯(DPH)作为荧光探针的细胞积累研究表明,DPH 负载的 LNEs 在 HeLa 细胞中的积累明显低于单独的 DPH。这些结果表明,即使 LNEs 本身不能有效地在 HeLa 细胞中积累,LNEs 也是 TXL 的一种有用载体。